Final Results of Peginterferon Alfa-2b Add-on during Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients - a Multicenter Randomized Controlled Trial (PEGON Study)

被引:0
|
作者
Chi, Heng [1 ]
Xie, Qing [2 ]
Zhang, Ning-Ping [3 ]
Qi, Xun [4 ]
Liang, Chen [4 ]
Guo, Simin [2 ]
Guo, Qing [2 ]
Arends, Pauline [1 ]
Wang, Jiyao [3 ]
Verhey, Elke [1 ]
de Knegt, Robert J. [1 ]
Hansen, Bettina E. [1 ]
Janssen, Harry L. [1 ,5 ]
机构
[1] Erasmus MC Univ Med Ctr Rotterdam, Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Infect Dis, Shanghai 200030, Peoples R China
[3] Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, Shanghai 200433, Peoples R China
[4] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Hepatitis Dis, Shanghai 200433, Peoples R China
[5] Univ Toronto, Toronto Gen & Western Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2002
引用
收藏
页码:1183A / 1183A
页数:1
相关论文
共 50 条
  • [1] Addition of Peginterferon Alfa-2b During Long-term Nucleos(t)ide Analogue Therapy Increases HBeAg Seroconversion and HBsAg Decline - Week 48 Results From a Multicenter Randomized Controlled Trial (PEGON Study)
    Chi, Heng
    Xie, Qing
    Zhang, Ning-Ping
    Qi, Xun
    Liang, Chen
    Guo, Simin
    Guo, Qing
    Arends, Pauline
    Wang, Ji-Yao
    Verhey, Elke
    de Knegt, Robert J.
    Hansen, Bettina E.
    Janssen, Harry L.
    [J]. HEPATOLOGY, 2014, 60 : 1106A - 1106A
  • [2] Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t) ide Analogue: A Randomized, Controlled Trial (PEGON)
    Chi, Heng
    Hansen, Bettina E.
    Guo, Simin
    Zhang, Ning Ping
    Qi, Xun
    Chen, Liang
    Guo, Qing
    Arends, Pauline
    Wang, Ji-Yao
    Verhey, Elke
    de Knegt, Robert J.
    Xie, Qing
    Janssen, Harry L. A.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 215 (07): : 1085 - 1093
  • [3] SWITCH OR ADD-ON PEGINTERFERON TO CHRONIC HEPATITIS B PATIENTS ALREADY ON NUCLEOS(T)IDE ANALOGUE THERAPY (SWAP STUDY): FINAL RESULTS
    Lim, Seng Gee
    Yang, Wei Lyn
    Chang, Jason Pik Eu
    Ngu, Jeffrey
    Tan, Yi-Lyn Jessica
    Ahmed, Taufique
    Dan, Yock Young
    Lee, Yin Mei
    Lee, Guan Huei
    Tan, Poh Seng
    Phyo, Wah Wah
    Khin, Lay Wai
    Lee, Chris
    Tay, Amy
    Chan, Edwin
    [J]. HEPATOLOGY, 2019, 70 : 125A - 126A
  • [4] Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients
    He, D.
    Guo, S.
    Zhu, P.
    Tao, S.
    Li, M.
    Huang, H.
    Wang, J.
    Wang, Y.
    Ding, M.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (10) : O687 - O693
  • [5] ADDITION OF PEGINTERFERON ALFA-2a INCREASES HBsAg DECLINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL. (PAS STUDY)
    Farag, Mina S.
    Fung, Scott K.
    Van Campenhout, Margo
    Van Erpecum, Karel J.
    Wong, David K. H.
    Boonstra, Andre
    Verhey, Elke
    De Man, Robert A.
    Liem, Kin Seng
    Hansen, Bettina E.
    Janssen, Harry L. A.
    [J]. HEPATOLOGY, 2019, 70 : 127A - 128A
  • [6] Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Cheng, Jun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Mohamed, Rosmawati
    Guan, Richard
    Lee, Tzong-Hsi
    Chang, Wen-Hsiung
    Huang Zhenfei
    Ye, Zhang
    Xu, Daozhen
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (04) : 509 - 516
  • [7] COMBINATION THERAPY WITH PEGINTERFERON ALFA-2a AND A NUCLEOS(T)IDE ANALOGUE FOR HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: RESULTS OF A LARGE, RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Su, W. -W.
    Hsu, C. -W.
    Lee, C. -M.
    Peng, C. -Y.
    Chuang, W. -L.
    Kao, J. -H.
    Chien, R. -N.
    Chu, H. -C.
    Huang, Y. -H.
    Liaw, Y. -F.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S47 - S47
  • [8] Peginterferon alfa-2b alone or in combination with lamivudine for chronic HBeAg-positive hepatitis B: a randomized controlled trial.
    Janssen, HLA
    van Zonneveld, M
    Senturk, H
    Zeuzem, S
    Akarca, U
    Cakaloglu, Y
    Simon, K
    Kit, TSM
    Gerken, G
    de Man, RA
    Niesters, HGM
    Schalm, SW
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A11 - A11
  • [9] Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China
    Sun, Jian
    Ding, Huiguo
    Chen, Guofeng
    Wang, Guiqiang
    Wei, Lai
    Zhang, Jiming
    Xie, Qing
    Wan, Mobin
    Tang, Hong
    Chen, Shijun
    Gao, Zhiliang
    Wang, Yuming
    Zhang, Dazhi
    Huang, Wenxiang
    Sheng, Jifang
    Ning, Qin
    Yang, Dongliang
    Lu, Jian
    Pan, Chen
    Yang, Yuxiu
    Wang, Jue
    Sun, Chuanzhen
    Wang, Qixin
    Hou, Jinlin
    [J]. BMC GASTROENTEROLOGY, 2019, 19 (1)
  • [10] Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China
    Jian Sun
    Huiguo Ding
    Guofeng Chen
    Guiqiang Wang
    Lai Wei
    Jiming Zhang
    Qing Xie
    Mobin Wan
    Hong Tang
    Shijun Chen
    Zhiliang Gao
    Yuming Wang
    Dazhi Zhang
    Wenxiang Huang
    Jifang Sheng
    Qin Ning
    Dongliang Yang
    Jian Lu
    Chen Pan
    Yuxiu Yang
    Jue Wang
    Chuanzhen Sun
    Qixin Wang
    Jinlin Hou
    [J]. BMC Gastroenterology, 19